Champions Oncology (CSBR) Free Cash Flow Growth (5y) (2015 - 2026)
Champions Oncology (CSBR) Free Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Champions Oncology |
82.77 Mn |
75.76 Mn |
13.89 Mn |
| Date | Value |
|---|
| Jan 31, 2026 |
-7.19% |
| Oct 31, 2025 |
-45.81% |
| Jul 31, 2025 |
19.00% |
| Apr 30, 2025 |
17.20% |
| Jan 31, 2025 |
26.80% |
| Oct 31, 2024 |
-19.94% |
| Jul 31, 2024 |
18.15% |
| Apr 30, 2024 |
-25.56% |
| Jan 31, 2024 |
-16.01% |
| Oct 31, 2023 |
34.59% |
| Jul 31, 2023 |
-108.36% |
| Apr 30, 2023 |
-48.22% |
| Jan 31, 2023 |
17.22% |
| Oct 31, 2022 |
62.60% |
| Jul 31, 2022 |
19.79% |
| Apr 30, 2022 |
28.84% |
| Jan 31, 2022 |
45.91% |
| Oct 31, 2021 |
45.08% |
| Jul 31, 2021 |
22.40% |
| Apr 30, 2021 |
-32.23% |
